1. Medtech Insight

CES 2023 Turnout Will Double Last Year’s; AARP AgeTech Takes Center Stage

 
• By Marion Webb

CES 2023 will be dedicating two days of programming to digital health, and AARP will be featuring 18 start-ups, panel discussions, programming, and pitching events.

CES
• Source: Shutterstock

The Consumer Technology Association says it expects more than 100,000 attendees at the 2023 International Consumer Electronics Show (CES) 5-8 January in Las Vegas, which is more than double than last year’s turnout. 

Andy Miller, AARP senior vice president of innovation and product development, will be among those flocking to the “most influential...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from Medtech Insight

Expert Panels Remain Tough On Manufacturers And Their Notified Bodies

 
• By Amanda Maxwell

The EU’s extra layer of checks on clinical evidence is proving a difficult, and sometimes humiliating process, for many device companies whose products have come under the spotlight.

Rising Oncology Start-ups Recognized For Breakthrough Cancer Research

 
• By Natasha Barrow

The Cancer Research Horizons Innovation Awards took place on July 10. Medtech Insight spoke to nominees for the women’s entrepreneur of the year award: Mireia Crispin-Ortuzar, CEO of 52 North Health; Anita Grigoriadis, CEO of PharosAI; and Maria Giovanna Lizio, Founder of WILD-Imaging Technology.

HeartFlow Takes Another Crack At Public Markets With $100M IPO Filing

 
• By Marion Webb

AI heart imaging company HeartFlow filed for a $100m IPO after scrapping its 2022 SPAC plans. It remains unprofitable but is betting on FDA clearances, Medicare coverage and a demand for AI-powered diagnostics to win over investors.